Organovo Holdings (ONVO) has a profit margin of -7605.93%, below the Healthcare sector average of 17.63%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
The latest profit margin for ONVO is -7605.93% as of September 2026. That compares with -1416.43% in the prior-year period — down 437.0% year over year. That is below the Healthcare sector average of 17.63%. Investors often review this figure alongside Organovo Holdings's historical trend and sector peers before judging valuation or financial health.
Over the past year, ONVO's profit margin moved from -1416.43% to -7605.93% — a 437.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Organovo Holdings's valuation or profitability profile.
Against Healthcare companies, ONVO currently prints -7605.93% for profit margin, while the sector average sits near 17.63%. That is roughly 43245.6% below the sector mean. Large gaps often invite a closer look at Organovo Holdings's growth, margins, and balance sheet.
Profit Margin shows how effectively Organovo Holdings converts resources into returns. At -7605.93%, ONVO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1416.43% in the prior-year period — down 437.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting ONVO's profit margin (-7605.93%), review year-over-year change from -1416.43%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.